Skip to main content

Table 1 Patients’ baseline characteristics

From: Oral PSORI-CM01, a Chinese herbal formula, plus topical sequential therapy for moderate-to-severe psoriasis vulgaris: pilot study for a double-blind, randomized, placebo-controlled trial

 

CHM group

placebo group

Number of subjects

7

10

Sex

 Male

7

8

 Female

0

2

Age, years (Mean, SD)

45.43, 11.84

41.60, 13.24

 Min-Max

29 to 59

24 to 62

PASI, (Mean, SD)

13.19, 3.66

11.67, 4.17

 (min-max)

(10.1 to 20.4)

(6.5 to 17.6)

Disease duration, months (minimum to maximum)

252 to 601

21 to 192

 (Mean, SD)

144.57, 73.77

86.20, 54.02

Job, n (%)

 Worker

2 (29)

1 (10)

 Farmer

2 (29)

1 (10)

 Cadres

0 (0)

1 (10)

 Clerk

1 (14)

5 (50)

 Retired or unemployed

0

0

 Freelance work

1 (14)

2 (20)

 Others

1 (14)

0

Marital status, n(%)

 Married

5 (63)

6 (60)

 Unmarried

3 (38)

4 (40)

Education, n(%)

 Illiterate

1 (14)

1(10)

 Middle school

2 (29)

0

 High school

3 (43)

2 (20)

 College graduate

1 (14)

7 (70)

Family history, n(%)

0

 

 With

0

5 (50)

 Without

7 (100)

5 (50)

BMI, (Mean, SD)

22.76, 3.70

24.16, 2.67

Stage, n(%)

 Active

0

0

 Stable

7 (100)

10 (100)

 Regressive

0

0

  1. CHM Chinese herbal medicine, BMI body mass index, PASI Psoriasis Area Severity Index, SD standard deviation